Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Let's do it this way

Was this the proposal that was requesting the Company to violate Delaware law, was not a proper subject for stockholder action under Delaware law, and was vague and indefinite?

http://www.sec.gov/divisions/corpfin/cf-noaction/14a-8/2008/patriotscientificcorp082108-14a8.pdf

Perhaps, a valid proposal would have been included on the proxy, without the need to expend $7,000 on one for which simple DD would have indicated the flaws which predicated the refusal?

Shouldn't the pitfalls that await the lay person be at least knowable to those qualified in Law?

.

.

.

Be well

Share
New Message
Please login to post a reply